Transmission

HCV RNA Detected in IVIG Related to Type of Screening Initially Performed

Published in Hepatitis Weekly, July 3rd, 1995

HCV RNA detected in lots of Gammagard intravenous immunoglobulin was related to the type of anti-HCV screening performed on starting plasma, reported researchers from the U.S. Food and Drug Administration (FDA), Bethesda, Maryland.

M.W. Yu, and colleagues, Center for Biologics Evaluation and Research, FDA, said that the detection of HCV RNA in Gammagard lots was in relation to the type of anti-HCV screening that was performed on the starting plasma and the number of case reports received by Baxter Healthcare Corporation, the manufacturer of Gammagard ("Hepatitis C Transmission Associated with Intravenous Immunoglobulins," the Lancet, May 6, 1995;345:1173-1174).

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (1995-07-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry